Author:
BAO Wu’an,ZHOU Xia,GU Feiying,LIN Juan,LI Bin
Publisher
China Science Publishing & Media Ltd.
Reference17 articles.
1. ARELLANO E A, DÍAZ V D, RODRÍGUEZ J. Current status and future directions in unresectable stage Ⅲ non-small cell lung cancer[J]. J Clin Transl Res, 2020, 6(4): 109-120..
2. 杨森, 谢颂平, 黄杰. 可手术切除的局部进展期非小细胞肺癌患者新辅助治疗研究进展[J]. 实用心脑肺血管病杂志, 2022, 30(3): 131-136..
3. YANG Sen, XIE Songping, HUANG Jie. Progress of neoadjuvant therapy for resectable locally advanced non-small cell lung cancer[J]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, 2022, 30(3): 131-136. (in Chinese).
4. DOVEDI S J, ADLARD A L, LIPOWSKA-BHALLA G. Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade. Cancer Res, 2014, 74: 5458-5468.
5. HERRERA F G, BOURHIS J, COUKOS G. Radio-therapy combination opportunities leveraging immunity for the next oncology practice. CA Cancer J Clin, 2017, 67: 65-85.